151 related articles for article (PubMed ID: 163856)
1. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
Piessens WF; Churchill WH; David
J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
[TBL] [Abstract][Full Text] [Related]
2. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
3. In vitro activation of mouse macrophages by rat lymphocyte mediators.
Fidler IJ; Darnell JH; Budmen MB
J Immunol; 1976 Aug; 117(2):666-73. PubMed ID: 950467
[TBL] [Abstract][Full Text] [Related]
4. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
5. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
6. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.
Churchill WH; Piessens WF; Sulis CA; David JR
J Immunol; 1975 Sep; 115(3):781-6. PubMed ID: 50373
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.
Cameron DJ; Churchill WH
J Clin Invest; 1979 May; 63(5):977-84. PubMed ID: 447836
[TBL] [Abstract][Full Text] [Related]
8. Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.
Piessens WF
J Immunol; 1977 Jul; 119(1):167-72. PubMed ID: 194981
[TBL] [Abstract][Full Text] [Related]
9. Guinea pig lymphotoxin. II. Study of its mechanism of action. Its differentiation from migration inhibitory factor and interferon.
Goguel AF; Nauciel C
Ann Immunol (Paris); 1974; 125 C(5):789-802. PubMed ID: 4617553
[No Abstract] [Full Text] [Related]
10. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
Hammond ME; Selvaggio SS; Dvorak HF
J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
Bonventre PF; Straus D; Baughn RE; Imhoff J
J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
[TBL] [Abstract][Full Text] [Related]
12. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
Viadro MM
Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells.
Reed WP; Lucas ZJ
J Immunol; 1975 Aug; 115(2):395-404. PubMed ID: 1097513
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of humoral factors released by macrophages in rat lymphocyte reactivity in vitro. I. Influence of humoral factors released by sensitized peritoneal macrophages on normal lymphocyte reactivity.
Brajczewska-Fischer W; Ryzewska AG
Arch Immunol Ther Exp (Warsz); 1980; 28(1):19-26. PubMed ID: 6968190
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
16. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
17. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
[TBL] [Abstract][Full Text] [Related]
18. Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice.
Preston PM; Hart PD; Brown IN
Immunology; 1977 Jan; 32(1):33-41. PubMed ID: 139359
[TBL] [Abstract][Full Text] [Related]
19. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
Postlethwaite AE; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
[TBL] [Abstract][Full Text] [Related]
20. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
Osteen RT; Piessens WF; David JR; Churchill WH
J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
